CGP 57813 - CAS 150608-41-6
Catalog number:
150608-41-6
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C43H58N4O8
Molecular Weight:
758.94
COA:
Inquire
Targets:
HIV
Description:
CGP 57813 has been found to be a HIV-1 protease inhibitor that has been once developed by Novartis.
Publictions citing BOC Sciences Products
  • >> More
Purity:
98%
Appearance:
Powder
Synonyms:
Cgp 57813; Cgp-57813; Cgp57813; Carbamic acid, (2-hydroxy-4-((4-methoxyphenyl)methyl)-5-((2-methyl-1-(((2-(4-morpholinyl)-2-oxo-1-(phenylmethyl)ethyl)amino)carbonyl)propyl)amino)-5-oxo-1-(phenylmethyl)pentyl)-, 1,1-dimethylethyl ester, (1S-(1R*,2R*,4S*,5(
Storage:
Store in a cool and dry place and at 0 - 4 °C for short term (days to weeks) or -20 °C for long term (months to years).
MSDS:
Inquire
Quality Standard:
In-house standard
Quantity:
Milligram-Grams
InChIKey:
DZUIFTBFVIXAMZ-YHKVADFHSA-N
InChI:
InChI=1S/C43H58N4O8/c1-29(2)38(40(50)44-36(27-31-15-11-8-12-16-31)41(51)47-21-23-54-24-22-47)46-39(49)33(25-32-17-19-34(53-6)20-18-32)28-37(48)35(26-30-13-9-7-10-14-30)45-42(52)55-43(3,4)5/h7-20,29,33,35-38,48H,21-28H2,1-6H3,(H,44,50)(H,45,52)(H,46,49)/t3
Canonical SMILES:
CC(C)C(C(=O)NC(CC1=CC=CC=C1)C(=O)N2CCOCC2)NC(=O)C(CC3=CC=C(C=C3)OC)CC(C(CC4=CC=CC=C4)NC(=O)OC(C)(C)C)O
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related HIV Products


CAS 1416258-16-6 (±)-BI-D

(±)-BI-D
(CAS: 1416258-16-6)

Approximately 2.4–2.9 μM of BI-D was required to inhibit 50% of HIV-Luc infection of WT and Hdgfrp2 KO cells, while the IC50 decreased dramatically, to 160–200 ...

CAS 174022-42-5 Bevirimat

Bevirimat
(CAS: 174022-42-5)

Bevirimat, also known as MPC-4326 and PA-457, is an anti-HIV drug derived from a betulinic acid-like compound, first isolated from Syzygium claviflorum, a Chine...

CAS 333353-44-9 NBD-556

NBD-556
(CAS: 333353-44-9)

NBD-556 is small molecule mimetic of CD4. NBD-556 recognizes the HIV-1 envelope protein gp120 and induces restructuring of gp120 analogous to CD4 binding. The C...

CAS 159989-64-7 Nelfinavir

Nelfinavir
(CAS: 159989-64-7)

Nelfinavir is a HIV protease inhibitor; antiretroviral; and anti-tumor agent.

CAS 174484-41-4 Tipranavir

Tipranavir
(CAS: 174484-41-4)

Tipranavir, a nonpeptidic HIV protease inhibitor (NPPI), inhibits the enzymatic activity and dimerization of HIV-1 protease, exerts potent activity against mult...

CAS 147221-93-0 Delavirdine mesylate

Delavirdine mesylate
(CAS: 147221-93-0)

Delavirdine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It is used as part of highly active antiretroviral therapy (HAART) for the treatment of...

CAS 229005-80-5 TAK-779

TAK-779
(CAS: 229005-80-5)

TAK-779 is a potent, dual antagonist at chemokine receptors CCR2 and CCR5 with IC50 = 1.4 nM at CCR5 and 2.3 nM at CCR2. Antagonists of both CCR2 and CCR5 such ...

CAS 1415559-43-1 CDK9-IN-1

CDK9-IN-1
(CAS: 1415559-43-1)

Among CDKs, CDK9 is a validated pathological target in HIV infection, inflammation and cardiac hypertrophy; however selective CDK9 inhibitors are still not avai...

CAS 1051375-19-9 Dolutegravir sodium

Dolutegravir sodium
(CAS: 1051375-19-9)

Dolutegravir sodium salt is a HIV integrase inhibitor(IC50= 2.7 nM), modest activity against raltegravir-resistant signature mutants Y143R, Q148K, N155H, and G1...

PD 135390
(CAS: 150351-31-8)

PD 135390 has been found to be a HIV-1 protease inhibitor that could probably be effective against HIV infections.

CAS 134678-17-4 Lamivudine

Lamivudine
(CAS: 134678-17-4)

Lamivudine is a potent nucleoside analog reverse transcriptase inhibitor, used for treatment of chronic HBV and HIV/AIDS.

CAS 697761-98-1 Elvitegravir

Elvitegravir
(CAS: 697761-98-1)

Elvitegravir (EVG, JTK-303/GS-9137) is an HIV integrase inhibitor for HIV-1 IIIB, HIV-2 EHO and HIV-2 ROD with IC50 of 0.7 nM, 2.8 nM and 1.4 nM, respectively.

CAS 62956-48-3 Gomisin G

Gomisin G
(CAS: 62956-48-3)

Gomisin G, carboxylic acid with additional oxygen functions, exhibited the most potent anti-HIV activity with EC50 and therapeutic index (TI) values of 0.006 mi...

BMS585248
(CAS: 619331-12-3)

BMS585248 is a highly potent and novel human immunodeficiency virus type 1 (HIV-1) attachment inhibitor with 4-fluoro-6-azaindole core heterocycles. It targets ...

CAS 500287-72-9 Rilpivirine

Rilpivirine
(CAS: 500287-72-9)

A novel non-nucleoside reverse transcriptase inhibitor. Rilpivirine seems to be well tolerated with less CNS disturbance than Efavirenz, and has non-teratogenic...

CAS 871038-72-1 Raltegravir

Raltegravir
(CAS: 871038-72-1)

Raltegravir is a potent, selective, and orally bioavailable inhibitor of HIV integrase (IC50 = 15 nM). It is metabolized primarily by uridine diphosphate glucur...

CAS 1051375-16-6 Dolutegravir (GSK1349572)

Dolutegravir (GSK1349572)
(CAS: 1051375-16-6)

Dolutegravir (GSK1349572) is a two-metal-binding HIV integrase inhibitor with IC50 of 2.7 nM, modest activity against raltegravir-resistant signature mutants Y1...

CAS 206361-99-1 Darunavir

Darunavir
(CAS: 206361-99-1)

Darunavir is a second generation protease inhibitor that targets the HIV-1 protease. It demonstrates extremely potent activity against the infectivity and repli...

CAS 106362-32-7 Peptide T

Peptide T
(CAS: 106362-32-7)

Peptide T is an HIV entry inhibitor that acts by blocking chemokine-5 receptors (CCR5), currently under clinical trials for the treatment of HIV-related neurolo...

CGP 53820
(CAS: 149267-24-3)

CGP 53820 has been found to be a HIV-1 Protease pseudosymmetric inhibitor that could probably be effective in the treatment of HIV infections.

Quick Inquiry

Verification code

Featured Items